- Home
- VOC vs SLGL Comparison
VOC vs SLGL Comparison
Compare VOC & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- SLGL
- Stock Information
- Founded
- VOC 2010
- SLGL 1997
- Country
- VOC United States
- SLGL Israel
- Employees
- VOC N/A
- SLGL N/A
- Industry
- VOC Oil & Gas Production
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- SLGL Health Care
- Exchange
- VOC Nasdaq
- SLGL Nasdaq
- Market Cap
- VOC 51.3M
- SLGL 49.4M
- IPO Year
- VOC 2011
- SLGL 2018
- Fundamental
- Price
- VOC $2.73
- SLGL $22.79
- Analyst Decision
- VOC
- SLGL
- Analyst Count
- VOC 0
- SLGL 0
- Target Price
- VOC N/A
- SLGL N/A
- AVG Volume (30 Days)
- VOC 90.4K
- SLGL 30.5K
- Earning Date
- VOC 01-01-0001
- SLGL 08-15-2025
- Dividend Yield
- VOC 23.06%
- SLGL N/A
- EPS Growth
- VOC N/A
- SLGL N/A
- EPS
- VOC 0.57
- SLGL N/A
- Revenue
- VOC $11,024,911.00
- SLGL $23,931,000.00
- Revenue This Year
- VOC N/A
- SLGL N/A
- Revenue Next Year
- VOC N/A
- SLGL $31.17
- P/E Ratio
- VOC $4.71
- SLGL N/A
- Revenue Growth
- VOC N/A
- SLGL 264.86
- 52 Week Low
- VOC $2.44
- SLGL $4.01
- 52 Week High
- VOC $5.69
- SLGL $26.89
- Technical
- Relative Strength Index (RSI)
- VOC 44.18
- SLGL 67.74
- Support Level
- VOC $2.64
- SLGL $21.00
- Resistance Level
- VOC $2.78
- SLGL $23.91
- Average True Range (ATR)
- VOC 0.11
- SLGL 2.62
- MACD
- VOC 0.01
- SLGL 0.27
- Stochastic Oscillator
- VOC 52.00
- SLGL 66.14
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.